Publicacións (27) Publicacións de Emilio Paredes Galán

filter_list

2026

  1. Benefit of coronary stenting using available intracoronary tools in high-risk patients. The OPTI-XIENCE study

    International Journal of Cardiology, Vol. 442

2025

  1. Medical Costs and Economic Impact of Hyperkalemia in a Cohort of Heart Failure Patients with Reduced Ejection Fraction

    Journal of Clinical Medicine, Vol. 14, Núm. 1

2024

  1. Nutritional intervention in chronic heart failure patients: A randomized controlled clinical trial

    Medicina Clinica, Vol. 163, Núm. 11, pp. 549-556

  2. Repetitive ambulatory levosimendan as a bridge to heart transplantation

    Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 290-301

2023

  1. Overlapping versus single long stents in long chronic total occlusions: insights of the Iberian CTO Registry

    Minerva cardiology and angiology, Vol. 71, Núm. 3, pp. 284-293

2022

  1. Telemedicine consultation and evolutionary model in outpatient care of cardiovascular processes

    REC: CardioClinics, Vol. 57, Núm. 2, pp. 97-106

2021

  1. Contemporary Management of Severe Symptomatic Aortic Stenosis

    Journal of the American College of Cardiology, Vol. 78, Núm. 22, pp. 2131-2143

  2. Impact of Comorbidities and Antiplatelet Regimen on Platelet Reactivity Levels in Patients Undergoing Transcatheter Aortic Valve Implantation

    Journal of cardiovascular pharmacology, Vol. 78, Núm. 3, pp. 463-473

  3. Value of non-apical echocardiographic views in the up-grading of patients with aortic stenosis

    Scandinavian Cardiovascular Journal, Vol. 55, Núm. 5, pp. 279-286

2020

  1. Characteristics and one-year outcomes in elderly patients hospitalised with heart failure and preserved, mid-range and reduced ejection fraction

    Revista Espanola de Geriatria y Gerontologia, Vol. 55, Núm. 4, pp. 195-200

  2. Influence of Valve Type and Antiplatelet Regimen on Platelet Reactivity After TAVI: Subanalysis of the REAC-TAVI Trial

    The Journal of invasive cardiology, Vol. 32, Núm. 12, pp. 446-452

2019

  1. Assessment of Platelet REACtivity After Transcatheter Aortic Valve Replacement: The REAC-TAVI Trial

    JACC: Cardiovascular Interventions, Vol. 12, Núm. 1, pp. 22-32

  2. Differences between patient-driven adherence to vitamin K antagonists and direct oral anticoagulants. Do few missed doses matter? ACO-MEMS Study

    Thrombosis Research, Vol. 179, pp. 20-27

2018

  1. Effect of beta-blocker dose on mortality after acute coronary syndrome

    Revista Portuguesa de Cardiologia, Vol. 37, Núm. 3, pp. 239-245

  2. Health Literacy and Health Outcomes in Very Old Patients With Heart Failure

    Revista Espanola de Cardiologia, Vol. 71, Núm. 3, pp. 178-184

  3. Safety of Direct Oral Anticoagulants and Vitamin K Antagonists in Oldest Old Patients: A Prospective Study

    Journal of the American Medical Directors Association, Vol. 19, Núm. 11, pp. 936-941

2017

  1. Geometrical model and numerical simulation of a severe stenotic aortic valve

    23rd Congress of the European Society of Biomechanics

  2. The frailty syndrome is associated with adverse health outcomes in very old patients with stable heart failure: A prospective study in six Spanish hospitals

    International Journal of Cardiology, Vol. 236, pp. 296-303

2016

  1. A hybrid model for extracting the aortic valve in 3D computerized tomography and its application to calculate a new calcium score index

    Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics)

  2. The frailty syndrome and mortality among very old patients with symptomatic severe aortic stenosis under different treatments

    International Journal of Cardiology, Vol. 224, pp. 125-131